No major differences ... and discounted brand-name drugs. The report provides estimated price thresholds that CMS should ...

Chloe Thornton, GlobalData's company analyst, also recently observed that GSK has major problems with a lack ... The biggest vaccine brand it has acquired in the deal is Bexsero, a new vaccine ...

GSK is currently the market leader in the meningococcal vaccine market, racking up sales of £1.26 billion (almost $1.6 billion) last year across the Bexsero and Menveo brands, but is having to ...

having the business as part of GSK gave it more stability, letting the pharma side of the business take more risks. Read more: Two huge drugmakers are spinning off iconic brands like Advil ...

With Sunday’s Academy Awards ceremony in the rearview mirror, GSK is looking ahead to a potential blockbuster premiere of its ...

GSK has drawn on a vast bank of images and conversations from ... In compiling a recent case for long-term, sustained investment in brand, we were able to support key marketing principles with ...

GSK is relocating to a property in the Boston area, a major life sciences hub. The departure of GSK leaves GI Partners, the property owner, in a potentially difficult financial situation as they ...